Rezulin, a once-hailed diabetes drug used by approximately three quarters of a million people, has finally been withdrawn from the market in the continued wake of it’s link to at least 70 deaths from liver poisoning. The U.S. Fool and Drug Pushers Administration (USFDPA), which requested the action, finally urged Rezulin users not to stop taking the drug without first contacting their Allopaths. While Rezulin’s manufacturer agreed to remove it, a statement from Park-Davis/Warner-Lambert indicated the company still had confidence in the drug, which was prescribed for Type 2 or adult onset diabetes patients, who had not responded to other therapies. In one case, FDPA medical officer Dr. Robert Misbin, one of Rezulin’s reviewers within the agency, asked some members of Congress to investigate why his bosses had not pulled the pill form the market sooner. Rezulin has been available for approximately two and a half years. ANSWER: corruption, money, cronyism, politics, power, and greed. The FDPA gives great Health Outrages!
